Work

Pharmacological Interventions Effective in Improving Exercise Capacity in Heart Failure

Year: 2018

Type: review

Abstract: Heart failure (HF) is characterised by exercise intolerance, which substantially impairs quality of life (QOL) and prognosis. The aim of this review is to summarise the state of the art on pharmacological interventions that are able to improve exercise capacity in HF. Ivabradine, trimetazidine and intravenous iron are the only drugs included in the European Society of Cardiology HF guidelines that have consistently been shown to positively affect functional capacity in HF. The beneficial effects on HF symptoms, physical performance and QOL using these pharmacological approaches are described.

Source: Cardiac failure review

DOI: 10.15420/cfr.2018:8:2

Authors: Cristiana Vitale, Ilaria Spoletini, Giuseppe MC Rosano

Institution: IRCCS San Raffaele Roma

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,146